EQRx
(NASDAQ) EQRX
EQRx Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$83.79M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
EQRX News
EQRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout EQRx
Industry
Pharmaceuticals
Sector
Health CareEmployees
362
CEO
Melanie I. Nallicheri, MBA
Website
www.eqrx.comHeadquarters
Cambridge, MA 02139, US
EQRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
14%
Return on Capital
-25%
Return on Assets
14%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$355.88M
EBITDA
$355.88M
Operating Cash Flow
$287.27M
Capital Expenditure
$1.13M
Free Cash Flow
$288.40M
Cash & ST Invst.
$1.40B
Total Debt
$3.83M
EQRx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
362
N/A
Net Income
$82.63M
-3.3%
EBITDA
$13.08M
+114.5%
Quarterly Fundamentals
Net Cash
$1.21B
-19.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$2.06M
-17.5%
Return on Assets
14.12%
N/A
Return on Invested Capital
-25.36%
N/A
Free Cash Flow
$61.91M
+0.3%
Operating Cash Flow
$61.91M
+0.3%